The Biden administration announced Thursday that drug companies receiving research funding from HHS’ emergency response arm, the Administration for Strategic Preparedness and Response, will have to commit to a “fair price” – not more than they charge in other countries. Host Chelsea Cirruzzo talks with POLITICO health care reporter Robert King about the Biden administration's efforts to curb high prescription drug prices.
2023 state abortion battles: What to expect
Can Mark Cuban disrupt prescription drugs?
When Bernie Sanders gets the HELP committee gavel
The FDA's struggles on flavored e-cigs
Running the NDAA's numbers on global health funding
New data sheds more light on long Covid
States face brutal virus fallout
Competition is coming for a top drug
Who's the next Fred Upton?
Developing the RSV vaccine
Unlocking health data
Ex-FDA vaccine inspectors call for better training
Top pharma group seeks postmortem on lobbying after drug pricing loss
Elon Musk wants to put a chip in your brain
The states making another run at expanding Medicaid in 2023
Covid forced rural health care to go virtual. Providers don’t want to go back.
These 'Abortion Pirates' want equal access to abortion pills worldwide
The challenges of long Covid and federal disability policies
Using environmental laws to curb abortions
Long Covid’s funding shortfall
Create your
podcast in
minutes
It is Free